Injectable forms are often considered more effective for systemic targets (tendons, joints, muscles) because they bypass digestive breakdown and provide higher bioavailability
GHK-Cu is not in the page's active Category 2 table
Wilding JPH, Batterham RL, Calanna S
If you experience any suspected side effects, you can report them via the MHRA Yellow Card scheme
This study was limited in scope: Conducted on 24 rats, not humans Administered a single dose Designed only to demonstrate that some absorption is possible Importantly, the study itself includes this disclaimer: This proof-of-concept study is not intended to provide guidance on the sublingual dosing of semaglutide in humans, or dosing conversion from other forms to sublingual administration. This means the only research behind these products cannot confirm whether they work in humans or provide guidance on appropriate dosing
Therefore, Siddiqui et al